FDA authorizes emergency use of convalescent plasma to treat COVID-19
The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on emergency use of convalescent plasma to treat COVID-19
May 21, 2024
- May 22, 2024
4th Annual Healthcare House Call Conference
September 4, 2024
11th Annual TMT One-on-One Conference
September 12, 2024
